BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1186 related articles for article (PubMed ID: 19609863)

  • 1. Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD).
    Tipoe GL; Ho CT; Liong EC; Leung TM; Lau TY; Fung ML; Nanji AA
    Histol Histopathol; 2009 Sep; 24(9):1161-9. PubMed ID: 19609863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A voluntary oral ethanol-feeding rat model associated with necroinflammatory liver injury.
    Tipoe GL; Liong EC; Casey CA; Donohue TM; Eagon PK; So H; Leung TM; Fogt F; Nanji AA
    Alcohol Clin Exp Res; 2008 Apr; 32(4):669-82. PubMed ID: 18341647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways.
    Xiao J; Ho CT; Liong EC; Nanji AA; Leung TM; Lau TY; Fung ML; Tipoe GL
    Eur J Nutr; 2014 Feb; 53(1):187-99. PubMed ID: 23515587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets high in corn oil and fish oil.
    Polavarapu R; Spitz DR; Sim JE; Follansbee MH; Oberley LW; Rahemtulla A; Nanji AA
    Hepatology; 1998 May; 27(5):1317-23. PubMed ID: 9581686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic effects of insulin-sensitizing drugs on nonalcoholic fatty liver disease: experiment with rats].
    Zhang DM; Zhang GY; Wang T; Zhong HJ; Chen WK
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1279-83. PubMed ID: 16796890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pioglitazone ameliorates nonalcoholic steatohepatitis by down-regulating hepatic nuclear factor-kappa B and cyclooxygenases-2 expression in rats.
    Zhao JS; Zhu FS; Liu S; Yang CQ; Chen XM
    Chin Med J (Engl); 2012 Jul; 125(13):2316-21. PubMed ID: 22882855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary saturated fatty acids down-regulate cyclooxygenase-2 and tumor necrosis factor alfa and reverse fibrosis in alcohol-induced liver disease in the rat.
    Nanji AA; Zakim D; Rahemtulla A; Daly T; Miao L; Zhao S; Khwaja S; Tahan SR; Dannenberg AJ
    Hepatology; 1997 Dec; 26(6):1538-45. PubMed ID: 9397995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatoprotective effect of the ethanol extract of Vitis thunbergii on carbon tetrachloride-induced acute hepatotoxicity in rats through anti-oxidative activities.
    Deng JS; Chang YC; Wen CL; Liao JC; Hou WC; Amagaya S; Huang SS; Huang GJ
    J Ethnopharmacol; 2012 Aug; 142(3):795-803. PubMed ID: 22698911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease.
    Gao H; Zeng Z; Zhang H; Zhou X; Guan L; Deng W; Xu L
    Biol Pharm Bull; 2015; 38(5):694-702. PubMed ID: 25947915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice.
    Kubota N; Kado S; Kano M; Masuoka N; Nagata Y; Kobayashi T; Miyazaki K; Ishikawa F
    Clin Exp Pharmacol Physiol; 2013 Jul; 40(7):422-30. PubMed ID: 23611112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of silkworm pupa oil on hydrochloric acid/ethanol-induced gastric ulcers.
    Long X; Zhao X; Wang W; Zhang Y; Wang H; Liu X; Suo H
    J Sci Food Agric; 2019 Apr; 99(6):2974-2986. PubMed ID: 30479041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease.
    Hong XZ; Li LD; Wu LM
    Clin Exp Pharmacol Physiol; 2007; 34(1-2):27-35. PubMed ID: 17201732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress and regulation of anti-oxidant enzymes in cytochrome P4502E1 transgenic mouse model of non-alcoholic fatty liver.
    Kathirvel E; Chen P; Morgan K; French SW; Morgan TR
    J Gastroenterol Hepatol; 2010 Jun; 25(6):1136-43. PubMed ID: 20594230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic expression of hepatic thioredoxin mRNA in rats with non-alcoholic fatty liver disease.
    Duan XY; Zhao HP; Fan JG
    J Dig Dis; 2010 Apr; 11(2):94-100. PubMed ID: 20402835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of traditional chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis.
    Gao Y; Song LX; Jiang MN; Ge GY; Jia YJ
    Inflammation; 2008 Apr; 31(2):121-32. PubMed ID: 18302012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nuclear factor-κB and angiotensin II receptor type 1 on the pathogenesis of rat non-alcoholic fatty liver disease.
    Tan DY; Shi HY; Li CP; Zhong XL; Kang M
    World J Gastroenterol; 2015 May; 21(19):5877-83. PubMed ID: 26019451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure.
    Zaitone SA; Barakat BM; Bilasy SE; Fawzy MS; Abdelaziz EZ; Farag NE
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun; 388(6):587-600. PubMed ID: 25708949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triterpenoid-rich fraction from Ilex hainanensis Merr. attenuates non-alcoholic fatty liver disease induced by high fat diet in rats.
    Cui WX; Yang J; Chen XQ; Mao Q; Wei XL; Wen XD; Wang Q
    Am J Chin Med; 2013; 41(3):487-502. PubMed ID: 23711137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of hepatic lipid mediators associated with intake of high-fat diet for 12 weeks in endotoxemic rats using LC-ESI-MS/MS.
    Nishiokada A; Miyoshi M; Fujiwara M; Aoyama-Ishikawa M; Maeshige N; Takahashi M; Hamada Y; Usami Y; Honda M; Arita M; Usami M
    Clin Nutr; 2015 Aug; 34(4):685-93. PubMed ID: 25131602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease.
    Li Z; Yang S; Lin H; Huang J; Watkins PA; Moser AB; Desimone C; Song XY; Diehl AM
    Hepatology; 2003 Feb; 37(2):343-50. PubMed ID: 12540784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.